Admission hypomagnesemia and hypermagnesemia increase the risk of acute kidney injury

Background: The association between admission serum magnesium (Mg) levels and risk of in-hospital acute kidney injury (AKI) is limited. The aim of this study was to assess the risk of developing AKI in all hospitalized patients with various admission Mg levels. Methods: This is a single-center retro...

Full description

Saved in:
Bibliographic Details
Published inRenal failure Vol. 37; no. 7; pp. 1175 - 1179
Main Authors Cheungpasitporn, Wisit, Thongprayoon, Charat, Erickson, Stephen B.
Format Journal Article
LanguageEnglish
Published England Informa Healthcare 09.08.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: The association between admission serum magnesium (Mg) levels and risk of in-hospital acute kidney injury (AKI) is limited. The aim of this study was to assess the risk of developing AKI in all hospitalized patients with various admission Mg levels. Methods: This is a single-center retrospective study conducted at a tertiary referral hospital. All hospitalized adult patients who had admission Mg available from January to December 2013 were analyzed in this study. Admission Mg was categorized based on its distribution into six groups (less than 1.5, 1.5-1.7, 1.7-1.9, 1.9-2.1, 2.1-2.3 and greater than 2.3 mg/dL). The primary outcome was in-hospital AKI occurring after hospital admission. Logistic regression analysis was performed to obtain the odds ratio of AKI of various admission Mg levels using Mg with lowest AKI incidence (1.9-2.1 mg/dL) as the reference group. Results: Of 9241 patients enrolled, AKI occurred in 1124 patients (12.2%). The lowest incidence of AKI was when serum Mg was within 1.7-1.9 and 1.9-2.1 mg/dL. A U-shaped curve emerged demonstrating higher incidences of AKI associated with both hypoMg (<1.7) and hyperMg (>2.1). After adjusting for potential confounders, both hypoMg (<1.5 mg/dL) and hyperMg (>2.3 mg/dL) were associated with an increased risk of developing AKI with odds ratios of 1.70 (95% CI 1.31-2.18) and 1.42 (95% CI 1.11-1.81), respectively. Conclusion: Both admission hypoMg and hyperMg were associated with an increased risk for in-hospital AKI.
AbstractList Background: The association between admission serum magnesium (Mg) levels and risk of in-hospital acute kidney injury (AKI) is limited. The aim of this study was to assess the risk of developing AKI in all hospitalized patients with various admission Mg levels. Methods: This is a single-center retrospective study conducted at a tertiary referral hospital. All hospitalized adult patients who had admission Mg available from January to December 2013 were analyzed in this study. Admission Mg was categorized based on its distribution into six groups (less than 1.5, 1.5-1.7, 1.7-1.9, 1.9-2.1, 2.1-2.3 and greater than 2.3 mg/dL). The primary outcome was in-hospital AKI occurring after hospital admission. Logistic regression analysis was performed to obtain the odds ratio of AKI of various admission Mg levels using Mg with lowest AKI incidence (1.9-2.1 mg/dL) as the reference group. Results: Of 9241 patients enrolled, AKI occurred in 1124 patients (12.2%). The lowest incidence of AKI was when serum Mg was within 1.7-1.9 and 1.9-2.1 mg/dL. A U-shaped curve emerged demonstrating higher incidences of AKI associated with both hypoMg (<1.7) and hyperMg (>2.1). After adjusting for potential confounders, both hypoMg (<1.5 mg/dL) and hyperMg (>2.3 mg/dL) were associated with an increased risk of developing AKI with odds ratios of 1.70 (95% CI 1.31-2.18) and 1.42 (95% CI 1.11-1.81), respectively. Conclusion: Both admission hypoMg and hyperMg were associated with an increased risk for in-hospital AKI.
The association between admission serum magnesium (Mg) levels and risk of in-hospital acute kidney injury (AKI) is limited. The aim of this study was to assess the risk of developing AKI in all hospitalized patients with various admission Mg levels. This is a single-center retrospective study conducted at a tertiary referral hospital. All hospitalized adult patients who had admission Mg available from January to December 2013 were analyzed in this study. Admission Mg was categorized based on its distribution into six groups (less than 1.5, 1.5-1.7, 1.7-1.9, 1.9-2.1, 2.1-2.3 and greater than 2.3 mg/dL). The primary outcome was in-hospital AKI occurring after hospital admission. Logistic regression analysis was performed to obtain the odds ratio of AKI of various admission Mg levels using Mg with lowest AKI incidence (1.9-2.1 mg/dL) as the reference group. Of 9241 patients enrolled, AKI occurred in 1124 patients (12.2%). The lowest incidence of AKI was when serum Mg was within 1.7-1.9 and 1.9-2.1 mg/dL. A U-shaped curve emerged demonstrating higher incidences of AKI associated with both hypoMg (<1.7) and hyperMg (>2.1). After adjusting for potential confounders, both hypoMg (<1.5 mg/dL) and hyperMg (>2.3 mg/dL) were associated with an increased risk of developing AKI with odds ratios of 1.70 (95% CI 1.31-2.18) and 1.42 (95% CI 1.11-1.81), respectively. Both admission hypoMg and hyperMg were associated with an increased risk for in-hospital AKI.
The association between admission serum magnesium (Mg) levels and risk of in-hospital acute kidney injury (AKI) is limited. The aim of this study was to assess the risk of developing AKI in all hospitalized patients with various admission Mg levels.BACKGROUNDThe association between admission serum magnesium (Mg) levels and risk of in-hospital acute kidney injury (AKI) is limited. The aim of this study was to assess the risk of developing AKI in all hospitalized patients with various admission Mg levels.This is a single-center retrospective study conducted at a tertiary referral hospital. All hospitalized adult patients who had admission Mg available from January to December 2013 were analyzed in this study. Admission Mg was categorized based on its distribution into six groups (less than 1.5, 1.5-1.7, 1.7-1.9, 1.9-2.1, 2.1-2.3 and greater than 2.3 mg/dL). The primary outcome was in-hospital AKI occurring after hospital admission. Logistic regression analysis was performed to obtain the odds ratio of AKI of various admission Mg levels using Mg with lowest AKI incidence (1.9-2.1 mg/dL) as the reference group.METHODSThis is a single-center retrospective study conducted at a tertiary referral hospital. All hospitalized adult patients who had admission Mg available from January to December 2013 were analyzed in this study. Admission Mg was categorized based on its distribution into six groups (less than 1.5, 1.5-1.7, 1.7-1.9, 1.9-2.1, 2.1-2.3 and greater than 2.3 mg/dL). The primary outcome was in-hospital AKI occurring after hospital admission. Logistic regression analysis was performed to obtain the odds ratio of AKI of various admission Mg levels using Mg with lowest AKI incidence (1.9-2.1 mg/dL) as the reference group.Of 9241 patients enrolled, AKI occurred in 1124 patients (12.2%). The lowest incidence of AKI was when serum Mg was within 1.7-1.9 and 1.9-2.1 mg/dL. A U-shaped curve emerged demonstrating higher incidences of AKI associated with both hypoMg (<1.7) and hyperMg (>2.1). After adjusting for potential confounders, both hypoMg (<1.5 mg/dL) and hyperMg (>2.3 mg/dL) were associated with an increased risk of developing AKI with odds ratios of 1.70 (95% CI 1.31-2.18) and 1.42 (95% CI 1.11-1.81), respectively.RESULTSOf 9241 patients enrolled, AKI occurred in 1124 patients (12.2%). The lowest incidence of AKI was when serum Mg was within 1.7-1.9 and 1.9-2.1 mg/dL. A U-shaped curve emerged demonstrating higher incidences of AKI associated with both hypoMg (<1.7) and hyperMg (>2.1). After adjusting for potential confounders, both hypoMg (<1.5 mg/dL) and hyperMg (>2.3 mg/dL) were associated with an increased risk of developing AKI with odds ratios of 1.70 (95% CI 1.31-2.18) and 1.42 (95% CI 1.11-1.81), respectively.Both admission hypoMg and hyperMg were associated with an increased risk for in-hospital AKI.CONCLUSIONBoth admission hypoMg and hyperMg were associated with an increased risk for in-hospital AKI.
Author Cheungpasitporn, Wisit
Thongprayoon, Charat
Erickson, Stephen B.
Author_xml – sequence: 1
  givenname: Wisit
  surname: Cheungpasitporn
  fullname: Cheungpasitporn, Wisit
  email: wcheungpasitporn@gmail.com
  organization: Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic
– sequence: 2
  givenname: Charat
  surname: Thongprayoon
  fullname: Thongprayoon, Charat
  organization: Department of Anesthesiology, Mayo Clinic
– sequence: 3
  givenname: Stephen B.
  surname: Erickson
  fullname: Erickson, Stephen B.
  organization: Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26099295$$D View this record in MEDLINE/PubMed
BookMark eNqFkEFr2zAUgEVJaZO2P2HDx12cSbJlW-yyEra1EOilhd7Ei_S8qrWlTLIp_veTSQJjh-0keHzfk_StyMJ5h4R8YHRdMCo_06apKOfPa06ZWDMq6rJmZ2TJBBd5RUu5IMuZyWfokqxifKWJbGp-QS55RaXkUizJ063pbYzWu-xl2vsefjqM2FvIwJl5hOGPmXU6IETMhhfMgo1vmW8z0OOA2Zs1DqdEvI5huibnLXQRb47nFXn6_u1xc5dvH37cb263uS5ZMeTNrtLAoCxRNgy4oWDAyKIqQTDUHNN7W14DZ5VGwUqzq7nmjeQi0XXRYHFFPh327oP_NWIcVPqMxq4Dh36MitWskIIVhUjoxyM67no0ah9sD2FSpxQJ-HIAdPAxBmyVtgMMqcwQwHaKUTWHV6fwag6vjuGTLf6yTxf8z_t68KxrfUr97kNn1ABT50MbwGkbZ_1fK34DM4CaZg
CitedBy_id crossref_primary_10_1093_ndt_gfac210
crossref_primary_10_1053_j_ajkd_2022_03_004
crossref_primary_10_3390_diagnostics11112119
crossref_primary_10_3390_medsci8030037
crossref_primary_10_1016_j_nefro_2020_11_020
crossref_primary_10_3390_diagnostics13152551
crossref_primary_10_3390_brainsci13040593
crossref_primary_10_1007_s00467_021_05331_1
crossref_primary_10_1007_s00424_019_02261_8
crossref_primary_10_1007_s10157_022_02245_6
crossref_primary_10_1002_ams2_334
crossref_primary_10_2147_CLEP_S311364
crossref_primary_10_1080_0886022X_2021_1960563
crossref_primary_10_3390_jcm9041104
crossref_primary_10_1002_clc_24168
crossref_primary_10_1111_hdi_12591
crossref_primary_10_1186_s12872_024_03864_5
crossref_primary_10_1007_s11096_025_01892_5
crossref_primary_10_1053_j_jrn_2024_12_006
crossref_primary_10_1038_s41598_020_69405_0
crossref_primary_10_1007_s40264_020_00947_y
crossref_primary_10_3389_fneur_2024_1433653
crossref_primary_10_3390_medsci9040060
crossref_primary_10_1016_j_ecoenv_2020_111809
crossref_primary_10_1155_2022_3893653
crossref_primary_10_1007_s00210_024_03583_w
crossref_primary_10_1080_21548331_2020_1724723
crossref_primary_10_3109_07435800_2015_1094088
crossref_primary_10_1016_j_jtemb_2017_01_001
crossref_primary_10_1136_bmjebm_2019_111322
crossref_primary_10_1111_tri_13932
crossref_primary_10_5937_jomb0_48779
crossref_primary_10_1080_0886022X_2023_2170244
crossref_primary_10_1111_ijcp_13745
crossref_primary_10_1016_j_nefroe_2022_01_005
crossref_primary_10_1002_jja2_12219
Cites_doi 10.1093/ejcts/ezu330
10.1053/j.ajkd.2013.07.025
10.1681/ASN.2007040394
10.1034/j.1399-6576.2000.00520.x
10.1093/ndt/gfp766
10.1038/kisup.2012.1
10.1172/JCI107851
10.1681/ASN.V1071616
10.1093/ndt/gfs268
10.1186/1471-2369-15-176
10.1001/jama.2014.15284
10.1161/01.CIR.102.19.2353
10.1016/0895-4356(94)90129-5
10.7326/0003-4819-150-9-200905050-00006
10.1590/S0100-879X2010007500002
10.1385/NCC:1:4:441
10.1053/j.ajkd.2013.04.018
10.1161/01.HYP.9.4.379
ContentType Journal Article
Copyright 2015 Informa Healthcare USA, Inc. 2015
Copyright_xml – notice: 2015 Informa Healthcare USA, Inc. 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.3109/0886022X.2015.1057471
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1525-6049
EndPage 1179
ExternalDocumentID 26099295
10_3109_0886022X_2015_1057471
1057471
Genre Article
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCATS NIH HHS
  grantid: UL1TR000135
GroupedDBID ---
00X
0YH
123
29P
36B
4.4
53G
5RE
AAPXX
ABDBF
ACGEJ
ACGFS
ACUHS
ADCVX
ADRBQ
ADXPE
AENEX
AFKVX
AJWEG
ALMA_UNASSIGNED_HOLDINGS
ARJSQ
BABNJ
BLEHA
CS3
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
GROUPED_DOAJ
H13
HZ~
M4Z
O9-
P2P
SV3
TDBHL
TFDNU
TFL
TFW
TUS
V1S
~1N
AAYXX
CITATION
.GJ
5VS
8G5
AALIY
AAORF
ABUWG
ABWCV
ADBBV
AFKRA
AFLEI
AJVHN
AOIJS
AWYRJ
AZQEC
BCNDV
BENPR
BPHCQ
BRMBE
CAG
CCPQU
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWQXO
DWTOO
ECM
EIF
GNUQQ
GUQSH
HYE
JENTW
M2O
M44
NPM
NUSFT
PHGZT
PIMPY
PQQKQ
PROAC
QQXMO
RPM
ZGI
ZXP
7X8
ID FETCH-LOGICAL-c413t-8b6ca1a44e981a2d0adad9364a51ec2e015f27a216ce514db72c2892581a738e3
IEDL.DBID 0YH
ISSN 0886-022X
1525-6049
IngestDate Fri Jul 11 06:10:00 EDT 2025
Thu Apr 03 07:00:50 EDT 2025
Tue Jul 01 04:23:05 EDT 2025
Thu Apr 24 23:01:23 EDT 2025
Wed Dec 25 09:05:33 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords hypomagnesemia
magnesium
hypermagnesemia
electrolytes
Acute kidney injury
dysmagnesemia
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c413t-8b6ca1a44e981a2d0adad9364a51ec2e015f27a216ce514db72c2892581a738e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.tandfonline.com/doi/pdf/10.3109/0886022X.2015.1057471?needAccess=true
PMID 26099295
PQID 1713951335
PQPubID 23479
PageCount 5
ParticipantIDs informaworld_taylorfrancis_310_3109_0886022X_2015_1057471
proquest_miscellaneous_1713951335
crossref_citationtrail_10_3109_0886022X_2015_1057471
pubmed_primary_26099295
crossref_primary_10_3109_0886022X_2015_1057471
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-08-09
PublicationDateYYYYMMDD 2015-08-09
PublicationDate_xml – month: 08
  year: 2015
  text: 2015-08-09
  day: 09
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Renal failure
PublicationTitleAlternate Ren Fail
PublicationYear 2015
Publisher Informa Healthcare
Publisher_xml – name: Informa Healthcare
References Altura BM (CIT0005) 1991; 10
CIT0010
CIT0021
CIT0020
CIT0001
CIT0012
CIT0011
CIT0022
Alfrey AC (CIT0023) 1974; 84
Altura BM (CIT0006) 1976; 35
Campos SB (CIT0019) 2001; 12
CIT0003
CIT0002
CIT0013
Agus ZS (CIT0009) 1999; 10
CIT0016
CIT0004
CIT0015
Altura BM (CIT0007) 1985; 4
KDIGO AKI Work Group (CIT0014) 2012; 2
CIT0018
CIT0017
CIT0008
References_xml – ident: CIT0002
  doi: 10.1093/ejcts/ezu330
– ident: CIT0021
  doi: 10.1053/j.ajkd.2013.07.025
– ident: CIT0020
  doi: 10.1681/ASN.2007040394
– volume: 84
  start-page: 153
  year: 1974
  ident: CIT0023
  publication-title: J Lab Clin Med.
– ident: CIT0017
  doi: 10.1034/j.1399-6576.2000.00520.x
– volume: 12
  start-page: A4057
  year: 2001
  ident: CIT0019
  publication-title: J Am Soc Nephrol.
– ident: CIT0015
  doi: 10.1093/ndt/gfp766
– volume: 10
  start-page: 167
  year: 1991
  ident: CIT0005
  publication-title: Magnes Trace Elem.
– volume: 2
  start-page: 1
  year: 2012
  ident: CIT0014
  publication-title: Kidney Int
  doi: 10.1038/kisup.2012.1
– ident: CIT0022
  doi: 10.1172/JCI107851
– volume: 10
  start-page: 1616
  year: 1999
  ident: CIT0009
  publication-title: J Am Soc Nephrol.
  doi: 10.1681/ASN.V1071616
– ident: CIT0010
  doi: 10.1093/ndt/gfs268
– ident: CIT0001
  doi: 10.1186/1471-2369-15-176
– ident: CIT0004
  doi: 10.1001/jama.2014.15284
– ident: CIT0018
  doi: 10.1161/01.CIR.102.19.2353
– ident: CIT0013
  doi: 10.1016/0895-4356(94)90129-5
– ident: CIT0012
  doi: 10.7326/0003-4819-150-9-200905050-00006
– volume: 35
  start-page: 2360
  year: 1976
  ident: CIT0006
  publication-title: Fed Proc.
– ident: CIT0011
  doi: 10.1590/S0100-879X2010007500002
– ident: CIT0016
  doi: 10.1385/NCC:1:4:441
– ident: CIT0003
  doi: 10.1053/j.ajkd.2013.04.018
– volume: 4
  start-page: 245
  year: 1985
  ident: CIT0007
  publication-title: Magnesium.
– ident: CIT0008
  doi: 10.1161/01.HYP.9.4.379
SSID ssj0015872
Score 2.2324812
Snippet Background: The association between admission serum magnesium (Mg) levels and risk of in-hospital acute kidney injury (AKI) is limited. The aim of this study...
The association between admission serum magnesium (Mg) levels and risk of in-hospital acute kidney injury (AKI) is limited. The aim of this study was to assess...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1175
SubjectTerms Acute kidney injury
Acute Kidney Injury - blood
Acute Kidney Injury - diagnosis
Acute Kidney Injury - etiology
Adult
Aged
Creatinine - blood
dysmagnesemia
electrolytes
Female
Glomerular Filtration Rate
Hospitalization
Humans
hypermagnesemia
hypomagnesemia
Incidence
Logistic Models
magnesium
Magnesium - blood
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Retrospective Studies
Risk Factors
Tertiary Care Centers
Title Admission hypomagnesemia and hypermagnesemia increase the risk of acute kidney injury
URI https://www.tandfonline.com/doi/abs/10.3109/0886022X.2015.1057471
https://www.ncbi.nlm.nih.gov/pubmed/26099295
https://www.proquest.com/docview/1713951335
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDI7QkBAXxJvxUpC4Fto0aZsjQkwTEpyYBKcqaRwYsG5i3YF_j912ExwGB46J4raxneRz7diMnaPWpNZqFRQiloGMZRpYYVQggXwyHsBndHf47j7pD-Tto5pHE07bsEqyoX2TKKLeq2lxG1tXIKE8lpe4MBI8eh4pMEvVhWol3SJfFaStqNLhU3_hSFBZXb-JSAKiaS7xLH_Mj-PpR_LS5RC0Pop6m2yjxZD8qhH6FluBcput3bVe8h02oIy4FN1a8pfPyXhknqnM5GhoOE6Zumg3XvQNSwKOU-AIBTlFmvOx56aYVcDfhq6ETxzxipzfZYPezcN1P2jLJwQFnkxVkNmkMJGREnQWGeFC44zTcSKNiqAQgLP2IjUiSgpA2ORsKgo0v4TC0WmcQbzHOuW4hAPGsemsCz2CWys1gPZOehtK49EgcRB2mZxzLS_a3OJU4uI9RxuDmJ3PmZ0Ts_OW2V12sSCbNMk1_iLQ30WSV_VfDd-UICG6X2nP5vLLUQjkFzEljGfTPEJDXVOdG9Vl-41gF5-D5p5GBKkO__HmI7ZOzTpsUB-zTvUxgxOEMpU9rZX1C0Ib574
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LT_MwDI8QSMAF8WY8g8S10EfSNkeEQOMxTkwapyhpHNj3QYegO_DfY7fdBAfgwLFp3DZ2Uv8cOzZjRzhrMmuVDIo4EYFIRBbY2MhAAPlkPIDP6exw7zbt9sXVQA4-nYWhsEqyoX2TKKL-V9Pips3ok9rEDNUJrowUdc-AIrNkXalW0DHyOYnKl8o3hPfdqSdB5nUBJyIJiKY5xfP9Y77opy_ZS7_HoLUuulhmSy2I5KeN1FfYDJSrbL7XusnXWJ9S4lJ4a8kf319Gz-aB6kw-Dw3HMVMT_Y6nbcOSkOMbcMSCnELN-chzU4wr4P-HroR37PEPWb_O-hfnd2fdoK2fEBSomqogt2lhIiMEqDwysQuNM04lqTAygiIGHLWPMxNHaQGIm5zN4gLtr1hi7yzJIdlgs-WohC3G8dJZF3pEt1YoAOWd8DYUxqNF4iDsMDHhmi7a5OJU4-JJo5FBzNYTZmtitm6Z3WHHU7KXJrvGbwTqs0h0VW9r-KYGCdH9SHs4kZ9GIZBjxJQwGr_pCC11RYVuZIdtNoKdfg7aewohpNz-w5sP2EL3rnejby5vr3fYIt2qYwjVLputXsewh7imsvv1xP0A6P3rMg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1dT9sw0JpAQrwgYIOVT0_iNWs-7CR-REBVtoF4WKXuybLjM3SDtKLpA_-euySt6EPZA49xfEl8d_bd5b4YO0OuyaxVMijiRAQiEVlgYyMDAeST8QA-p9zhm9u0PxA_hnIeTThtwyrJhvZNoYj6rKbNPXG-W1uYoerixkhR9AwpMEvWjWoFZZGvyxxlPbJ0-Ke_cCTIvO7fRCABwTRJPKsfsySeloqXrlZBa1HU22ZbrQ7Jzxui77BPUO6yjZvWS_6ZDagiLkW3lvzhZTJ-MvfUZvJpZDgumYboNF6MjUpSHKfAURXkFGnOx56bYlYB_zdyJbzgjL-I-S9s0Lv6fdEP2vYJQYGSqQpymxYmMkKAyiMTu9A441SSCiMjKGLAVfs4M3GUFoBqk7NZXKD5FUucnSU5JHtsrRyX8JVxvHTWhR6VWysUgPJOeBsK49EgcRB2mJhjTRdtbXFqcfGo0cYgZOs5sjUhW7fI7rDvC7BJU1zjfwDqLUl0Vf_V8E0LEoJ7F_bbnH4aiUB-EVPCeDbVERrqivrcyA7bbwi7-Bw09xRylTz4wJtP2cbdZU__ur79ecg26U4dQaiO2Fr1PINj1Goqe1Lz7SuTG-pk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Admission+hypomagnesemia+and+hypermagnesemia+increase+the+risk+of+acute+kidney+injury&rft.jtitle=Renal+failure&rft.au=Cheungpasitporn%2C+Wisit&rft.au=Thongprayoon%2C+Charat&rft.au=Erickson%2C+Stephen+B.&rft.date=2015-08-09&rft.pub=Informa+Healthcare&rft.issn=0886-022X&rft.eissn=1525-6049&rft.volume=37&rft.issue=7&rft.spage=1175&rft.epage=1179&rft_id=info:doi/10.3109%2F0886022X.2015.1057471&rft.externalDocID=1057471
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0886-022X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0886-022X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0886-022X&client=summon